Biotechnology Company Provides Major Update For Heart Failure Treatment Trial

Windtree Therapeutics, Inc. (“Windtree” or the “Company”), listed on the Nasdaq Capital Market under the ticker symbol WINT, has recently provided an update on the clinical and business development of istaroxime. This innovative biotechnology company focuses on developing therapies for critical conditions and diseases, emphasizing early and late-stage treatments. $Windtree Therapeutics (WINT.US)$